Ali McBride
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Neutropenia and Cancer Infections
- Hematology top 2%
- Hematopoietic Stem Cell Transplantation
Papers in
- Hematology 41
- Acute Myeloid Leukemia Research 14
- Hematopoietic Stem Cell Transplantation 13
- Oncology 46
- Neutropenia and Cancer Infections 19
- Co-authors
- Ivo L Abraham (51 shared papers)Faiz Anwer (29 shared papers)Marion Kimball Slack (18 shared papers)Brian L. Erstad (15 shared papers)Peter Westervelt (5 shared papers)ABDULAALI R. ALMUTAIRI (9 shared papers)Karen MacDonald (16 shared papers)Hani M. Babiker (14 shared papers)
- Journals
- Journal of Medical Economics (18 papers)Blood (16 papers)Transplantation and Cellular Therapy (13 papers)Future Oncology (10 papers)American Journal of Health-System Pharmacy (9 papers)
- Partner nations
- United StatesSaudi ArabiaJordan
In The Last Decade
Ali McBride
171 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 100
- Oncology 940
- Hematology 442
- Genetics 138
- Immunology 288
- Economics and Econometrics 353
Countries citing papers authored by Ali McBride
This map shows the geographic impact of Ali McBride's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali McBride with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali McBride more than expected).
Fields of papers citing papers by Ali McBride
This network shows the impact of papers produced by Ali McBride. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali McBride. The network helps show where Ali McBride may publish in the future.
Co-authors
The 25 scholars most cited alongside Ali McBride, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 184 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 152 | |
| 2 | 2020 | 144 | |
| 3 | 2019 | 109 | |
| 4 | 2016 | 107 | |
| 5 | 2018 | 98 | |
| 6 | 2013 | 96 | |
| 7 | 2017 | 96 | |
| 8 | 2018 | 87 | |
| 9 | 2017 | 81 | |
| 10 | 2017 | 78 | |
| 11 | 2012 | 65 | |
| 12 | 2019 | 60 | |
| 13 | 2016 | 59 | |
| 14 | 2015 | 56 | |
| 15 | 2012 | 46 | |
| 16 | 2013 | 45 | |
| 17 | 2016 | 40 | |
| 18 | 2018 | 40 | |
| 19 | 2017 | 37 | |
| 20 | 2017 | 36 |
About Ali McBride
Ali McBride is a scholar working on Hematology, Oncology, Economics and Econometrics, Genetics and Immunology, having authored 184 papers that have together received 3k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (27 papers), Neutropenia and Cancer Infections (19 papers), Acute Myeloid Leukemia Research (14 papers), Biosimilars and Bioanalytical Methods (14 papers), Pharmaceutical Economics and Policy (14 papers), Economic and Financial Impacts of Cancer (13 papers), Hematopoietic Stem Cell Transplantation (13 papers) and Chronic Lymphocytic Leukemia Research (11 papers). The work is most often cited by research in Oncology (940 citations), Hematology (442 citations), Genetics (138 citations), Immunology (288 citations) and Economics and Econometrics (353 citations). Ali McBride has collaborated with scholars based in United States, Saudi Arabia and Jordan. Frequent co-authors include Ivo L Abraham, Faiz Anwer, Marion Kimball Slack, Brian L. Erstad, Peter Westervelt, ABDULAALI R. ALMUTAIRI, Karen MacDonald, Hani M. Babiker, Jennifer R Martin and Irbaz Bin Riaz. Their work appears in journals such as Journal of Medical Economics, Blood, Transplantation and Cellular Therapy, Future Oncology and American Journal of Health-System Pharmacy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.